PECAM1 and neoplasm: Although CXCR2 was reported to be expressed also on the vascular endothelium, contributing to tumor angiogenesis [34], we failed to observe any changes in the frequency of CD31+ tumor infiltrating endothelial cells upon CXCR2 inhibition.